CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

By Q. Ostrom, H. Gittleman, Paul Farah, Annie Ondracek, Yanwen Chen, Yingli Wolinsky, N. Stroup, C. Kruchko, Jill S. Barnholtz-Sloan. Neuro-Oncology, 2013

1,916 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. (2012, methodology): “0–9), but excludes lymphoma and leukemia histologies (9590–9989) from all brain and CNS sites.(6) In contrast, CBTRUS reports data on all tumor morphologies located within the Consensus Conference site definition including lymphoma and other hematopoietic histologies (9590–9989), as well as olfactor”
The epidemiology of glioma in adults: a "state of the science" review. (2015, background): “A 2013 report noted that the Veterans Administration hospitals had ceased from 2005 to 2014 to report cancer cases diagnosed among military veterans.(12) The result was that 3%–8% of all male cancer cases were missing.”
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma (2014, methodology): “Observations extracted from the current study revealed that (1) a considerable proportion of SVs leading toGFI1 and GFI1B activation do not actually include the target gene itself; and (2) multiple distinct classes of SV including duplication, deletion, inversion and other complex rearrangements can”
Epidemiologic and Molecular Prognostic Review of Glioblastoma (2014, background): “2% of malignant primary brain and CNS tumors, 54% of all gliomas, and 16% of all primary brain and CNS tumors (2).”